Altria Group Inc. Chief Executive Marty Barrington is retiring and will be replaced by another 25-year company veteran. Mr. Barrington, who has held the top post for six years, will retire in May after a quarter of a century with the tobacco company, Altria said Thursday. His replacement is Howard Willard, 54, the company's current operating chief and former finance chief.
ApidraÂ® (insulin glulisine) is a prescription form of insulin used to treat type 1 diabetes and type 2 diabetes in adults. It is a rapid-acting insulin used to help control the spike in blood sugar levels that occurs after meals. It is typically used in combination with a long-acting insulin.
Sitagliptin is used alone or together with other medicines (e.g., insulin, glimepiride, metformin, or pioglitazone) to treat high blood sugar levels caused by type 2 diabetes. Normally, after you eat, your pancreas releases insulin to help your body store excess sugar for later use.itagliptin does not help patients who have insulin-dependent or type 1 diabetes, because they cannot produce insulin from their pancreas. Their blood sugar is best controlled with insulin injections.